MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
2. Industry_Business Architects & Consolidators
Industry: By Region (Globally)
Industry: U.S.(United States)
*Industry: Texas
*Industry: Houston
Leonardo Biosystems, Inc.
Parents
*Architects: Drug Delivery
*Architects: Nanomedicine (Drug Delivery)
*Industry: Houston
Portfolio Companies: Houston Technology Center
Texas Emerging Technology Fund (TETF)
UTHSC:Office of Technology Transfer
Venture Capital: Series A
Children
Dr. Bruce Given, Leonardo's CEO
Facilitates chemotherapy and biological anti-cancer agent delivery. The company’s first target market is refractory breast cancer.
Houston, Texas
Leonardo Biosystems Raises Half of $2.5M Debt Offering (2010)
Leonardo Biosystems receives $2.5M grant to accelerate commercialization of new technologies (2010)
Leonardo Biosystems receives second round of TETF money (2011)
Leonardo Biosystems uses multi-stage nanovector drug delivery technology, based on research by UTHSC-H’s Dr. Mauro Ferrari and colleagues
Renowned Researcher Dr. Mauro Ferrari Launches New Company to Battle Cancer (2006)
Series A $1.25M by OnBioVC (2012)